XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
EARNINGS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2022
EARNINGS PER SHARE  
Schedule of computation of basic and diluted net income per share

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

    

2022

    

2021

    

2022

    

2021

(Millions, except per share amounts)

​

​

​

​

​

​

​

​

​

​

​

​

Numerator

​

​

​

​

​

​

​

​

​

​

​

​

Income from continuing operations

​

$

134

​

$

206

​

$

358

​

$

737

Income (loss) from discontinued operations, net of income taxes

​

​

—

​

​

18

​

​

(1)

​

​

46

Net income

​

$

134

​

$

224

​

$

357

​

$

783

​

​

​

​

​

​

​

​

​

​

​

​

​

Denominator

​

​

​

​

​

​

​

​

​

​

​

​

Basic: Weighted average common stock

​

 

49.8

​

 

49.8

​

 

49.9

​

 

49.7

Weighted average effect of dilutive securities

​

​

​

​

​

​

​

​

​

​

​

​

Add: net effect of dilutive unvested restricted stock awards (1)

​

 

0.1

​

 

0.2

​

 

0.1

​

 

0.3

Diluted

​

 

49.9

​

 

50.0

​

 

50.0

​

 

50.0

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic EPS

​

​

​

​

​

​

​

​

​

​

​

​

Income from continuing operations

​

$

2.69

​

$

4.14

​

$

7.17

​

$

14.81

Income (loss) from discontinued operations

​

$

—

​

$

0.36

​

$

(0.01)

​

$

0.94

Net income per share

​

$

2.69

​

$

4.50

​

$

7.16

​

$

15.75

​

​

​

​

​

​

​

​

​

​

​

​

​

Diluted EPS

​

​

​

​

​

​

​

​

​

​

​

​

Income from continuing operations

​

$

2.69

​

$

4.11

​

$

7.16

​

$

14.74

Income (loss) from discontinued operations

​

$

—

​

$

0.36

​

$

(0.01)

​

$

0.94

Net income per share

​

$

2.69

​

$

4.47

​

$

7.15

​

$

15.68

(1)For the three and nine months ended September 30, 2022 and 2021, an insignificant amount of restricted stock awards were excluded from each calculation of weighted average dilutive common shares as the effect would have been anti-dilutive.